PMCCPMCCPMCC

Search tips
Search criteria 

Advanced


 
Formats
Article sections
Authors
Related links
Logo of heartHeartCurrent TOCInstructions to authors
 
Heart. 2005 December; 91(Suppl 5): v1–v52.
PMCID: PMC1876394
Copyright notice
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
b Prepared
Small right arrow pointing to: This article has been cited by other articles in PMC.
The Full Text of this article is available as a PDF (878K).
​
Figure 1
Figure 1
 Joint British Societies' cardiovascular disease (CVD) risk prediction chart: non-diabetic men.
Figure 2
Figure 2
 Joint British Societies' CVD risk prediction chart: non-diabetic women.
Figure 3
Figure 3
Risk thresholds and targets for blood pressure in asymptomatic people without CVD
Figure 4
Figure 4
 Recommendations for combining blood pressure drugs/ABCD rule.
Figure 5
Figure 5
(A) Absolute reduction in LDL cholesterol (mmol/l) and absolute reduction in risk of major cardiac event (MCE). (B) Both axes are on a log scale showing relative reduction in LDL cholesterol (mmol/l) and relative reduction in risk of MCE.
Figure 6
Figure 6
Risk thresholds and targets for blood cholesterol in asymptomatic people without CVD. †Assessed with CVD risk chart.
Figure 7
Figure 7
Risk thresholds and targets for plasma blood glucose in asymptomatic people without CVD. *Impaired glucose tolerance: 2 hour glucose in an OGTT [gt-or-equal, slanted] 7.8 mmol/l and [less-than-or-eq, slant] 11.0 mmol/l. OGTT, oral glucose tolerance test. See table 13.
Articles from Heart are provided here courtesy of
BMJ Group